<?xml version="1.0" encoding="UTF-8"?>
<p id="par0180">There are several ongoing clinical trials using repurposed clinical-stage or approved drugs such as remdesivir, favipiravir, lopinavir/ritonavir, hydroxychloroquine, and natural or semisynthetic products like quercetin [
 <xref rid="bib0355" ref-type="bibr">71</xref>,
 <xref rid="bib0360" ref-type="bibr">72</xref>], colchicine [
 <xref rid="bib0365" ref-type="bibr">73</xref>], tetrandrine [
 <xref rid="bib0370" ref-type="bibr">74</xref>], desferrioxamine B [
 <xref rid="bib0375" ref-type="bibr">75</xref>], azithromycin [
 <xref rid="bib0380" ref-type="bibr">[76]</xref>, 
 <xref rid="bib0385" ref-type="bibr">[77]</xref>, 
 <xref rid="bib0390" ref-type="bibr">[78]</xref>] (
 <xref rid="fig0050" ref-type="fig">Fig. 10</xref> ) are under investigation for treating COVID-19 patients, as well as several vaccines are in fast phases of clinical trials. Selected examples of natural products which are in current clinical trials to treat COVID-19 are shown below.
</p>
